Regarding hepatic impairment, the CHMP noted that the majority of valsartan is eliminated, mainly as unchanged drug in the bile, through hepatic clearance.
Maksapuudulikkuse kohta märkis inimravimite komitee, et enamik valsartaanist elimineeritakse peamiselt muutumatuna sapi kaudu maksakliirensi teel.